Fredun Pharmaceuticals Ltd (BOM:539730)

Q2 2026 Fredun Pharmaceuticals Ltd Earnings Call Transcript

Nov 11, 2025 / 07:00 AM GMT

Release Date Price: ₹570.08 (+5.00%)

Transcript

Key Points

Positve

Fredun Pharmaceuticals Ltd (BOM:539730) reported a 35% year-on-year increase in total income for Q2 FY26, reaching 145.229 crore.
EBITDA grew by 60% to 22.34 crore, with margins improving to 15.37%.
Net profit surged by 128% to 9.73 crore, indicating strong financial performance.
The company has expanded its presence to 52 international markets, showcasing its global reach.
Fredun Pharmaceuticals Ltd (BOM:539730) has entered the organized pet care service market through strategic acquisitions, enhancing its product and service offerings.

Negative

The company faces challenges in scaling up its manufacturing capacity, necessitating the expansion of its facility at Parga.
There is a reliance on outsourced production for certain products, which may impact cost efficiency.
The integration of new acquisitions like Vega.AI and One Pet Stop requires significant investment and management focus.
The company's ambitious growth plans, including a target for 51% revenue from the US by FY32, involve substantial risk and uncertainty.
Fredun Pharmaceuticals Ltd (BOM:539730) operates in a highly competitive market, which may pressure margins and market share.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

FRED.BO - Fredun Pharmaceuticals Ltd
Q2 2026 Fredun Pharmaceuticals Ltd Earnings Call
Nov 11, 2025 / 07:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Fredent Pharmaceuticals Limited Q2 and H1 FY26 results conference call. This conference call may contain forward-looking statements about the company which are based on beliefs, opinions, and expectations of the company as on date of this call. These statements are not guarantee of future performance and involve risk and uncertainties that are difficult to predict. As a reminder, all participant lines will be the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing, then 0 on your touchstone phone. Please note that this conference

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.